Linnea P. Cipriano

Representative matters include:

• Par Pharmaceutical, Inc., et al. v. Amneal Pharmaceuticals of New York, LLC, et al. (D. Del.): Representing Amneal in a patent infringement case related to a generic drug product for the treatment of hypotension.
• Regeneron Pharmaceuticals, Inc. v. Novartis Pharma AG, IPR2020-01317, -01318: Successfully defending against IPR challenges to Novartis’s patent related to a pre-filled syringe.
• Representing Fresenius Kabi in IPR and PGR proceedings at the PTAB.
• Representing Celltrion at the PTAB and in patent infringement litigations related to Celltrion’s rituximab and trastuzumab biosimilars.
• Merck Sharp & Dohme Corp. v. Actavis Labs. FL, Inc. et al. (D.N.J.): Representing Actavis at trial in a patent infringement case related to a generic antifungal drug.
• Tris Pharma, Inc. v. Actavis Labs. FL, Inc. (D. Del.): Representing Actavis at trial and on an appeal in a patent infringement case related to a generic version of a drug product for the treatment of ADHD.
• Intendis GmbH, et al. v. Glenmark Generics Limited et al. (D. Del.): Representing Glenmark at trial and on appeal in a patent infringement case related to a generic drug product for the treatment of rosacea. 
• Warner Chilcott Co., LLC et al. v. Teva Pharmaceuticals USA, Inc. (D.N.J.): Representing Teva at trial and on appeal in a patent infringement case related to a generic drug product for the treatment of osteoporosis.

Ms. Cipriano’s recent pro bono work includes:

• Representing American Bird Conservancy in a case brought under the federal Environmental Protection Act against New York State Department of Parks, Recreation, and Historic Preservation regarding protection of Piping Plovers in Jones Beach State Park.
• Representing an individual applying for political asylum in the U.S.
• Representing unaccompanied minors in family court and in petitions to USCIS